| Pharmaceutical active ingredients: |
| Bretylium Tosylate |
| Available forms, composition and doses of Bretylium in Dextrose 5%: |
| Injectable; Injection; Bretylium Tosylate 200 mg / 100 mlInjectable; Injection; Bretylium Tosylate 400 mg / 100 mlInjectable; Injection; Bretylium Tosylate 800 mg / 100 ml |
| Bretylium in Dextrose 5% medical category: |
| Human:Class III antiarrythmics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01BD02 - Bretylium Tosilate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Abbott |